Editorial: Fluorescent nanomaterials for biomedical applications

Abstract

In recent years, fluorescent nanoparticles have proven their utility in a wide range of biomedical backgrounds (Nannuri et al., 2023). These microscopic particles, which can be on the nanometer size, have special luminous features that make them useful in a wide range of medical applications (Sangubotla and Kim, 2023). Because they allow for the clear visualisation of cellular architecture and can act as disease indicators, therefore they find widespread application in imaging and diagnostics (Thakur and Kumar, 2023). Their compact size makes them ideal for focused medication delivery, which boosts therapeutic efficacy while reducing unwanted side effects. Fluorescent nanoparticles have become a prominent area of research in the field of biomedical applications, displaying distinct characteristics that exhibit considerable potential for enhancing diagnostics and therapeutic treatments. These nanomaterials, which are typically nanoscale in size, have outstanding fluorescence properties, allowing for sensitive and real-time imaging at the cellular and molecular levels. Fluorescent nanoparticles are used in a variety of biomedical research applications, including targeted drug administration, bioimaging, and biosensing. Their tunable features, including size, shape, and surface chemistry, allow them to be tailored for specific applications, enabling precise and efficient interactions with biological systems. Fluorescent nanoparticles are also useful for real-time tracking of molecular motion within living organisms and other biological processes (Malode and Shetti, 2023). Because of their versatility and biocompatibility, they show great potential as a tool in the pursuit of better personalised medicine and illness management (Roach, 2023)